Nuwellis, Inc. (NUWE)
USD 0.84
(-12.5%)
USD 0.84
(-12.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.86 Million USD | 3.76% |
| 2022 | 8.54 Million USD | 7.85% |
| 2021 | 7.92 Million USD | 6.45% |
| 2020 | 7.44 Million USD | 35.02% |
| 2019 | 5.51 Million USD | 10.26% |
| 2018 | 4.99 Million USD | 40.67% |
| 2017 | 3.55 Million USD | 175.64% |
| 2016 | 1.28 Million USD | 2084.75% |
| 2015 | 59 Thousand USD | -80.0% |
| 2014 | 295 Thousand USD | 400.0% |
| 2013 | 59 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 400.02 Thousand USD | 269.36% |
| 2009 | 108.3 Thousand USD | -74.34% |
| 2008 | 422.04 Thousand USD | -84.55% |
| 2007 | 2.73 Million USD | 117.99% |
| 2006 | 1.25 Million USD | 228.25% |
| 2005 | 381.76 Thousand USD | 1529.3% |
| 2004 | 23.43 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.19 Million USD | 18.15% |
| 2024 Q1 | 1.85 Million USD | -27.21% |
| 2023 Q4 | 2.55 Million USD | 5.76% |
| 2023 Q3 | 2.41 Million USD | 16.24% |
| 2023 FY | 8.86 Million USD | 3.76% |
| 2023 Q1 | 1.82 Million USD | -21.93% |
| 2023 Q2 | 2.07 Million USD | 13.64% |
| 2022 Q1 | 1.92 Million USD | 17.3% |
| 2022 Q2 | 2.21 Million USD | 14.9% |
| 2022 FY | 8.54 Million USD | 7.85% |
| 2022 Q4 | 2.33 Million USD | 13.27% |
| 2022 Q3 | 2.06 Million USD | -6.69% |
| 2021 Q3 | 1.85 Million USD | -26.12% |
| 2021 FY | 7.92 Million USD | 6.45% |
| 2021 Q2 | 2.5 Million USD | 30.76% |
| 2021 Q1 | 1.91 Million USD | -6.16% |
| 2021 Q4 | 1.64 Million USD | -11.39% |
| 2020 FY | 7.44 Million USD | 35.02% |
| 2020 Q1 | 1.63 Million USD | 19.24% |
| 2020 Q2 | 1.86 Million USD | 14.29% |
| 2020 Q3 | 1.9 Million USD | 2.2% |
| 2020 Q4 | 2.04 Million USD | 7.35% |
| 2019 Q2 | 1.67 Million USD | 38.02% |
| 2019 Q1 | 1.21 Million USD | -18.95% |
| 2019 FY | 5.51 Million USD | 10.26% |
| 2019 Q4 | 1.36 Million USD | 9.19% |
| 2019 Q3 | 1.25 Million USD | -25.34% |
| 2018 Q4 | 1.49 Million USD | 9.98% |
| 2018 Q3 | 1.36 Million USD | 24.02% |
| 2018 Q2 | 1.09 Million USD | 5.98% |
| 2018 Q1 | 1.03 Million USD | 24.79% |
| 2018 FY | 4.99 Million USD | 40.67% |
| 2017 FY | 3.55 Million USD | 175.64% |
| 2017 Q4 | 831 Thousand USD | -13.17% |
| 2017 Q3 | 957 Thousand USD | 10.76% |
| 2017 Q2 | 864 Thousand USD | -4.11% |
| 2017 Q1 | 901 Thousand USD | 20.78% |
| 2016 FY | 1.28 Million USD | 2084.75% |
| 2016 Q4 | 746 Thousand USD | 37.38% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | 543 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | 59 Thousand USD | -80.0% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | 59 Thousand USD | -66.67% |
| 2014 Q3 | 59 Thousand USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2014 FY | 295 Thousand USD | 400.0% |
| 2014 Q4 | 177 Thousand USD | 200.0% |
| 2014 Q1 | 59 Thousand USD | 0.0% |
| 2013 Q3 | 59 Thousand USD | 0.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 FY | 59 Thousand USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q3 | -50 Thousand USD | 0.0% |
| 2010 FY | 400.02 Thousand USD | 269.36% |
| 2009 FY | 108.3 Thousand USD | -74.34% |
| 2008 FY | 422.04 Thousand USD | -84.55% |
| 2007 FY | 2.73 Million USD | 117.99% |
| 2006 FY | 1.25 Million USD | 228.25% |
| 2005 FY | 381.76 Thousand USD | 1529.3% |
| 2004 FY | 23.43 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 26.495% |
| BrainsWay Ltd. | 31.78 Million USD | 72.113% |
| Cerus Corporation | 156.36 Million USD | 94.331% |
| Envoy Medical, Inc. | 316 Thousand USD | -2705.063% |
| electroCore, Inc. | 16.03 Million USD | 44.704% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -1276.398% |
| IceCure Medical Ltd | 3.22 Million USD | -174.512% |
| Inogen, Inc. | 315.66 Million USD | 97.192% |
| OrthoPediatrics Corp. | 148.73 Million USD | 94.04% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -265.074% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -2328.5% |
| MaxCyte, Inc. | 41.28 Million USD | 78.531% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -353.996% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -7903.756% |
| Orthofix Medical Inc. | 746.64 Million USD | 98.813% |
| PAVmed Inc | 2.45 Million USD | -261.501% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 60.638% |
| RxSight, Inc. | 89.07 Million USD | 90.049% |
| Sight Sciences, Inc. | 81.05 Million USD | 89.064% |
| SI-BONE, Inc. | 138.88 Million USD | 93.618% |
| TELA Bio, Inc. | 58.45 Million USD | 84.836% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 95.263% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 35.773% |
| Acutus Medical, Inc. | 7.16 Million USD | -23.73% |
| Talis Biomedical Corporation | 412 Thousand USD | -2051.456% |
| Spectral AI, Inc. | 18.05 Million USD | 50.908% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 10.51% |
| CVRx, Inc. | 39.29 Million USD | 77.442% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -815.035% |
| Bioventus Inc. | 512.34 Million USD | 98.27% |
| Venus Concept Inc. | 76.35 Million USD | 88.391% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 52.115% |
| LivaNova PLC | 1.15 Billion USD | 99.232% |
| 908 Devices Inc. | 50.22 Million USD | 82.353% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.162% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -11405.114% |
| NeuroPace, Inc. | 65.42 Million USD | 86.451% |
| LENSAR, Inc. | 42.16 Million USD | 78.977% |
| Apyx Medical Corporation | 52.34 Million USD | 83.067% |
| Cutera, Inc. | 212.36 Million USD | 95.826% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 73.428% |
| BioSig Technologies, Inc. | 18 Thousand USD | -49144.444% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 94.681% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 62.997% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.425% |
| Axonics, Inc. | 366.37 Million USD | 97.581% |
| Outset Medical, Inc. | 130.37 Million USD | 93.201% |
| IRIDEX Corporation | 51.86 Million USD | 82.911% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 93.491% |
| IRadimed Corporation | 65.56 Million USD | 86.48% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -653.741% |
| INVO Bioscience, Inc. | 3.02 Million USD | -193.454% |
| Telesis Bio, Inc. | 27.5 Million USD | 67.778% |
| Viemed Healthcare, Inc. | 183 Million USD | 95.156% |
| Varex Imaging Corporation | 811 Million USD | 98.907% |
| Quipt Home Medical Corp. | 221.74 Million USD | 96.003% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 87.093% |
| Dynatronics Corporation | 32.53 Million USD | 72.755% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -2.143% |
| Semler Scientific, Inc. | 68.18 Million USD | 87.0% |
| InMode Ltd. | 492.04 Million USD | 98.199% |
| Bruker Corporation | 2.96 Billion USD | 99.701% |
| Cytosorbents Corporation | 36.34 Million USD | 75.614% |
| DexCom, Inc. | 3.62 Billion USD | 99.755% |
| Align Technology, Inc. | 3.86 Billion USD | 99.77% |
| Viveve Medical, Inc. | 6.42 Million USD | -37.94% |
| ZimVie Inc. | 457.43 Million USD | 98.062% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 95.408% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -7903.756% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 98.815% |
| Profound Medical Corp. | 7.33 Million USD | -20.911% |
| Insulet Corporation | 1.69 Billion USD | 99.478% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 92.969% |
| iCAD, Inc. | 17.31 Million USD | 48.816% |
| Biotricity, Inc. | 12.06 Million USD | 26.521% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.201% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -42.853% |
| PAVmed Inc. | 2.45 Million USD | -261.501% |
| BIOLASE, Inc. | 49.16 Million USD | 81.971% |
| Beyond Air, Inc. | 1.15 Million USD | -664.797% |
| FONAR Corporation | 102.88 Million USD | 91.384% |
| AxoGen, Inc. | 159.01 Million USD | 94.426% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 96.77% |
| Inari Medical, Inc. | 493.63 Million USD | 98.204% |
| UFP Technologies, Inc. | 400.07 Million USD | 97.784% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -47555.914% |
| Tenon Medical, Inc. | 2.92 Million USD | -202.732% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -30.123% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.723% |
| Sintx Technologies, Inc. | 2.62 Million USD | -237.419% |
| NanoVibronix, Inc. | 2.28 Million USD | -288.261% |
| Quanterix Corporation | 122.36 Million USD | 92.756% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 63.68% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 95.58% |
| TransMedics Group, Inc. | 241.62 Million USD | 96.331% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 36.018% |
| NeuroMetrix, Inc. | 5.9 Million USD | -50.201% |
| Hyperfine, Inc. | 11.03 Million USD | 19.652% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 94.633% |
| Biomerica, Inc. | 5.41 Million USD | -63.693% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 82.469% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 94.996% |